Glumetza and Doxycycline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glumetza (metformin hydrochloride) and Doxycycline (doxycycline hyclate). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Glumetza and Doxycycline. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Glumetza?

Glumetza has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 1,968 Glumetza users. Check the latest studies of Glumetza.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,866 Doxycycline users. Check the latest studies of Doxycycline.



On Jul, 06, 2026

16 people who take Glumetza and Doxycycline together, and have interactions are studied.

Glumetza and Doxycycline drug interactions.

What are the common drug interactions of Glumetza and Doxycycline, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Abdominal pain
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Chest discomfort
  7. Diarrhoea
  8. Dyspnoea (difficult or laboured respiration)
  9. Gangrene (body tissue dies)
  10. Headache (pain in head)

male:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Multiple fractures
  4. Osteoporosis (bones weak and more likely to break)
  5. Anxiety
  6. Bone density decreased
  7. Depression
  8. Emotional distress
  9. Pain
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Glumetza and Doxycycline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Chest discomfort
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Headache (pain in head)
  6. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  7. Upper respiratory tract infection

50-59:

  1. Chronic kidney disease
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Depression
  7. Emotional distress
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Multiple fractures
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  4. Pruritus (severe itching of the skin)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Renal tubular necrosis (death of kidney tubules)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Hepatic steatosis (fatty liver disease)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 56.25%
  2. High Blood Pressure: 8 people, 50.00%
  3. Fungal Infection: 7 people, 43.75%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 43.75%
  5. Psoriasis (immune-mediated disease that affects the skin): 6 people, 37.50%
  6. Depression: 5 people, 31.25%
  7. High Blood Cholesterol: 5 people, 31.25%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 31.25%
  9. Indigestion: 4 people, 25.00%
  10. Laxative Supportive Care: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Glumetza and Doxycycline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glumetza and Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glumetza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glumetza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxycycline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and doxycycline hyclate (the active ingredients of Glumetza and Doxycycline, respectively), and Glumetza and Doxycycline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: